The Relathionship Between CD31 Immunohistochemical Expression and Meningioma Grading Differences

Nanggi Qoriatul Febriana; Rohadi Muhammad Rosyidi; Januarman Januarman; Adelia Riezka Rahim; Lale Maulin Prihatina

doi:10.29303/jbt.v25i1.8539

The Relathionship Between CD31 Immunohistochemical Expression and Meningioma Grading Differences

Authors

Nanggi Qoriatul Febriana , Rohadi Muhammad Rosyidi , Januarman Januarman , Adelia Riezka Rahim , Lale Maulin Prihatina

DOI:

10.29303/jbt.v25i1.8539

Published:

2025-03-09

Issue:

Vol. 25 No. 1 (2025): Januari - Maret

Keywords:

CD31/PECAM-1, immunohistochemistry, meningioma grading

Articles

Downloads

pdf

How to Cite

Febriana, N. Q., Rosyidi, R. M., Januarman, J., Rahim, A. R., & Prihatina, L. M. (2025). The Relathionship Between CD31 Immunohistochemical Expression and Meningioma Grading Differences. Jurnal Biologi Tropis, 25(1), 877–885. https://doi.org/10.29303/jbt.v25i1.8539

Download Citation

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Abstract

The proper management of meningioma patients requires a definitive diagnosis of the meningioma grade by examining the expression of CD31 in tumor blood vessels using immunohistochemical staining. This study aims to determine the relationship between CD31 immunohistochemical expression and the grading differences of meningiomas. Nine paraffin block samples from the surgical tissue of meningioma patients were used, with three samples each from grade I, grade II, and grade III meningiomas. Immunohistochemical staining for CD31 was then performed on each meningioma slide, and the samples were observed under a binocular light microscope with 200x magnification. The results showed CD31 expression in grade I as 90%, 40%, and 80%; in grade II as 80%, 80%, and 60%; and in grade III as 40%, 20%, and negative (0%). The statistical test results of this study indicate a strong negative correlation between CD31 immunohistochemical expression and meningioma grading differences. The higher the meningioma grade, the lower the CD31 expression found, and vice versa. This research is important to assist neurosurgeons in the proper management of meningioma patients, potentially preventing poor prognosis and complications. It is hoped that future studies will analyze the relationship between CD31 immunohistochemical expression with subtypes of each meningioma grade and their respective locations.

References

Barresi, V. (2011). Angiogenesis in meningiomas. In Brain Tumor Pathology (Vol. 28, Issue 2, pp. 99–106).

DOI : https://doi.org/10.1007/s10014-010-0012-2

Baxter, D. S., Orrego, A., Rosenfeld, J. V., & Mathiesen, T. (2014). An audit of immunohistochemical

marker patterns in meningioma. Journal of Clinical Neuroscience, 21(3), 421–426. DOI:

https://doi.org/10.1016/j.jocn.2013.06.008

Biswas, S., Charlesworth, P. J., Dh Turner, G., et al. (2012). CD31 Angiogenesis and Combined Expression

of HIF-1α & HIF-2α are Prognostic in Primary Clear-Cell Renal Cell Carcinoma (CC-RCC), but HIFα

Transcriptional Products are Not: Implications for Antiangiogenic Trials and HIFα Biomarker Studies

in Primary CC-RCC * SB and PJSC are Joint first authors Downloaded from.

http://carcin.oxfordjournals.org/

Boulagnon-Rombi, C., Fleury, C., Fichel, C., et al. (2017). Immunohistochemical approach to the differential

diagnosis of meningiomas and their mimics. Journal of Neuropathology and Experimental Neurology,

(4), 289–298. DOI : https://doi.org/10.1093/jnen/nlx008

Brady, J., Neal, J., Sadakar, N., & Gasque, P. (2004). Human Endosialin (Tumor Endothelial Marker 1) Is

Abundantly Expressed in Highly Malignant and Invasive Brain Tumors. In Journal of Neuropathology

and Experimental Neurology (Vol. 63). https://academic.oup.com/jnen/article/63/12/1274/2916540

Buerki, R. A., Horbinski, C. M., Kruser, T., et al. (2018). An overview of meningiomas. In Future Oncology,

(21), 2161–2177. Future Medicine Ltd. https://doi.org/10.2217/fon-2018-0006

Delisser, H. M., Christofidou-Solomidou, M., Strieter, R. M., Burdick, M. D., Robinson, C. S., Wexler, R.

S., Kerr, J. S., Garlanda, C., Merwin, J. R., Madri,’w, J. A., Albelda, S. M., & Milano, M. N. (1997).

Involvement of Endothelial PECAM-1/CD31 in Angiogenesis. In American Journal of Pathology (Vol.

, Issue 3).

De Divitiis, E., Esposito, F., Cappabianca, P., & Cavallo, L. M. (2008).Tuberculum Sellae Meningiomas :

High Route or Low Route? A Series of 51 Consecutive Cases Clinical Studies. Neurosurgery, 62(3),

–563. https://doi.org/10.1227/01.NEU.0000297113.72625.D1

Echalier, E. L., & Subramanian, P. S. (2021). Meningiomas of the Planum Sphenoidale and Tuberculum

Sella. In Journal of Neurological Surgery, Part B: Skull Base (Vol. 82, Issue 1, pp. 72–80). Thieme

Medical Publishers, Inc. https://doi.org/10.1055/s-0040-1722703

Garcia-Bustos, V. (2019). CD31 or CD34: which is the best marker for evaluating microvascular density in

renal cell carcinoma? Histology and Histopathology From Cell Biology to Tissue Engineering, 34.

https://doi.org/10.13140/RG.2.2.24951.98729

Jennings, R. N., Miller, M. A., & Ramos-Vara, J. A. (2012). Comparison of CD34, CD31, and Factor VIIIRelated Antigen Immunohistochemical Expression in Feline Vascular Neoplasms and CD34 Expression

in Feline Nonvascular Neoplasms. Veterinary Pathology, 49(3), 532–537.

https://doi.org/10.1177/0300985811429312

Khattab, A. Z. M., Ahmed, M. I., Fouad, M. A., & Essa, W. A. (2009). Significance of p53 and CD31 in

astrogliomas. Medical Oncology, 26(1), 86–92. https://doi.org/10.1007/s12032-008-9094-7

Kim, S. W., Roh, J., & Park, C. S. (2016). Immunohistochemistry for pathologists: Protocols, pitfalls, and

tips. In Journal of Pathology and Translational Medicine (Vol. 50, Issue 6, pp. 411–418). Seoul

National University. https://doi.org/10.4132/jptm.2016.08.08

Maggio, I., Franceschi, E., Tosoni, A., Nunno, V. Di, Gatto, L., Lodi, R., & Brandes, A. A. (2021).

Meningioma: Not always a benign tumor. A review of advances in the treatment of meningiomas. CNS

Oncology, 10(2). https://doi.org/10.2217/cns-2021-0003

Magill, S. T., & McDermott, M. W. (2020). Tuberculum sellae meningiomas. In Handbook of Clinical

Neurology (Vol. 170, pp. 13–23). Elsevier B.V. https://doi.org/10.1016/B978-0-12-822198-3.00024-0

Majchrzak, K., Kaspera, W., Szymaś, J., Bobek-Billewicz, B., Hebda, A., & Majchrzak, H. (2013). Markery

angiogenezy (CD31, CD34, rCBV) w utkaniu wysoko zróżnicowanych glejaków mózgu oraz ich

wartość rokownicza. Neurologia i Neurochirurgia Polska, 47(4), 325–331.

https://doi.org/10.5114/ninp.2013.36757

Miettinen, M. (2014). Immunohistochemistry of soft tissue tumours - review with emphasis on 10 markers.

In Histopathology (Vol. 64, Issue 1, pp. 101–118). https://doi.org/10.1111/his.12298

Ogasawara, C., Philbrick, B. D., & Adamson, D. C. (2021). Meningioma: A review of epidemiology,

pathology, diagnosis, treatment, and future directions. In Biomedicines (Vol. 9, Issue 3). MDPI AG.

https://doi.org/10.3390/biomedicines9030319

Pusztaszeri, M. P., Seelentag, W., & Bosman, F. T. (2006). Immunohistochemical expression of endothelial

markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. Journal of

Histochemistry and Cytochemistry, 54(4), 385–395. https://doi.org/10.1369/jhc.4A6514.2005

Ramos-Vara, J. A., Miller, M. A., Gilbreath, E., & Patterson, J. S. (2010). Immunohistochemical detection

of CD34, E-cadherin, claudin-1, glucose transporter 1, laminin, and protein gene product 9.5 in 28

canine and 8 feline meningiomas. Veterinary Pathology, 47(4), 725–737.

https://doi.org/10.1177/0300985810364528

Schlüter, A., Weller, P., Kanaan, O., Nel, I., Heusgen, L., Höing, B., Haßkamp, P., Zander, S., Mandapathil,

M., Dominas, N., Arnolds, J., Stuck, B. A., Lang, S., Bankfalvi, A., & Brandau, S. (2018). CD31 and

VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell

carcinoma. BMC Cancer, 18(1). https://doi.org/10.1186/s12885-018-4180-5

Sidabutar, R., Hermanto, Y., Sutiono, A. B., Naibaho, G., & Faried, A. (2024). Surgical treatment of

tuberculum sellae meningioma: A retrospective review of single institutional experience. Surgical

Neurology International, 15, 440. https://doi.org/10.25259/SNI_685_2024

Taskinen, M., Jantunen, E., Kosma, V. M., Bono, P., Karjalainen-Lindsberg, M. L., & Leppä, S. (2010).

Prognostic impact of CD31-positive microvessel density in follicular lymphoma patients treated with

immunochemotherapy. European Journal of Cancer, 46(13), 2506–2512.

https://doi.org/10.1016/j.ejca.2010.06.014

Tubre, T., Hacking, S., Alexander, A., Brickman, A., Delalle, I., Elinzano, H., & Donahue, J. E. (2022).

Prostate-Specific Membrane Antigen Expression in Meningioma: A Promising Theranostic Target.

Journal of Neuropathology and Experimental Neurology, 81(12), 1008–1017.

https://doi.org/10.1093/jnen/nlac089

Yao, X., Qian, C. N., Zhang, Z. F., Tan, M. H., Kort, E. J., Yang, X. J., Resau, J. H., & Teh, B. T. (2007).

Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic

implications. Clinical Cancer Research, 13(1), 161–169. https://doi.org/10.1158/1078-0432.CCR-06-

Yilmazer, D., Han, Ü., & Önal, B. (2007). A comparison of the vascular density of VEGF expression with

microvascular density determined with CD34 and CD31 staining and conventional prognostic markers

in renal cell carcinoma. International Urology and Nephrology, 39(3), 691–698.

https://doi.org/10.1007/s11255-006-9123-4

Zhang, T., Zhang, L., Gao, Y., Wang, Y., Liu, Y., Zhang, H., Wang, Q., Hu, F., Li, J., Tan, J., Wang, D. D.,

Gires, O., Lin, P. P., & Li, B. (2021). Role of aneuploid circulating tumor cells and CD31+ circulating

tumor endothelial cells in predicting and monitoring anti-angiogenic therapy efficacy in advanced

NSCLC. Molecular Oncology, 15(11), 2891–2909. https://doi.org/10.1002/1878-0261.13092

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.

The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.

Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.

The Relathionship Between CD31 Immunohistochemical Expression and Meningioma Grading Differences

Authors

DOI:

Published:

Issue:

Keywords:

Articles

Downloads

How to Cite

Downloads

Metrics

Abstract

References

License

Most read articles by the same author(s)

Similar Articles

Menu

Manuscript Template

visitor

Keywords

Mitra Kerja sama

Open Access Journals

Contact Us

Information

Share & Follow